Medifast, Inc.
Medifast, Inc. is classed by the SEC under Miscellaneous Food Preparations & Kindred Products (industry code 2090), based in Baltimore, MD. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $386 million and a loss of $19 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2090, Miscellaneous Food Preparations & Kindred Products); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.3 out of ten, 9 of 9 metrics filed: past 4.3 out of ten, present 4.2 out of ten, future 4.4 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 7.6 out of ten. No warning events in its filings since 2017. 76th percentile among 42 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 1.1 out of ten. -29.1% a year over 5 filed years; profitable in 4 of 5. 11th percentile among 42 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 6.1 out of ten. Share count shrank 0.9% a year. 43% of cash flow returned. Insiders: 2 sales, 11 purchases. 61st percentile among 32 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 6.4 out of ten. ROE -9%: lost 9¢ per shareholder dollar. Leverage 20%: owes 20¢ per asset dollar. 64th percentile among 42 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 1.7 out of ten. bottom 17% of 42 in its family; net margin -4.8%. 17th percentile among 42 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 3.4 out of ten. bottom 34% of 26 in its family for leadership. 34th percentile among 26 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 7.2 out of ten. top 28% of 42 in its family for room to expand. 72nd percentile among 42 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 1.2 out of ten. bottom 12% of 42 in its family for growth drivers. 12th percentile among 42 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 3.3 out of ten. bottom 33% of 39 in its family for expectations against reality. 33rd percentile among 39 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-17 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-03 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-03 (on EDGAR). Newest filing: Form 4, 2026-09-30. Filings on record since 1996. Read from EDGAR 2026-10-12.
Who runs it
Chard, Daniel R (Chairman & CEO); Johnson, Nicholas Mark (President); Maloney, James P. (Chief Financial Officer); Mackenzie, Jonathan Barrett (VP, Finance & CAO); Kiai, Parsa (director); Geary, Elizabeth A. (director); Rose, Jeffrey Matthew (director); Schlackman, Scott (director); Thomas, Andrea B (director); Xian, Ming (director). 10 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.